Impact of posteromedial papillary muscle infarction on mitral regurgitation during ST-segment elevation myocardial infarction.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 04 06 2019
accepted: 26 10 2019
pubmed: 11 11 2019
medline: 23 6 2020
entrez: 11 11 2019
Statut: ppublish

Résumé

The exact role of papillary muscle infarction (PMI) during the acute phase of acute ST-segment elevation myocardial infarction (STEMI) is not well understood, as existing data on the impact of PMI location is conflicting. We hypothesized that infarction of the posteromedial papillary muscle (PM-PMI) as determined by cardiac magnetic resonance imaging might be associated with an increased incidence of mitral valve regurgitation in the first week after STEMI. 242 patients with first STEMI underwent a late-enhancement (LGE-) cardiac magnetic resonance imaging within a median of 2 (IQR 2-5) days and echocardiography within 3 (IQR 2-5) days after primary angioplasty for the index event. PMI was scored based on short axis slices (AL-PMI: anterolateral PMI, PM-PMI, AL/PM-PMI: AL- and PM-PMI). Patients with PM-PMI had significantly higher odds (OR 2.62, p < 0.01) for the occurrence of mitral regurgitation than patients with no-PMI, AL-PMI or AL/PM-PMI. Furthermore, advanced age, non-anterior infarct location and longer pain-to-balloon time were identified as risk factors for the occurrence of mitral regurgitation. Binary logistic regression analysis revealed that PM-PMI is a predictor of mitral regurgitation independent of infarct location and age (OR 2.229, CI 1.078-4.903, p = 0.031). PM-PMI as determined by cardiac magnetic resonance imaging is an independent predictor of mitral regurgitation in the setting of acute STEMI. Our data might improve our understanding of the dynamic nature of functional mitral regurgitation.

Identifiants

pubmed: 31707554
doi: 10.1007/s10554-019-01726-2
pii: 10.1007/s10554-019-01726-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-511

Références

J Am Coll Cardiol. 2015 Mar 31;65(12):1231-1248
pubmed: 25814231
Circulation. 2013 Sep 10;128(11 Suppl 1):S248-52
pubmed: 24030415
J Cardiovasc Magn Reson. 2012 Jul 12;14:46
pubmed: 22788728
Am Heart J. 2008 May;155(5):959-65
pubmed: 18440348
Eur Heart J. 2015 May 1;36(17):1023-30
pubmed: 24927730
Circ Cardiovasc Imaging. 2013 Nov;6(6):890-8
pubmed: 23973868
J Thorac Cardiovasc Surg. 2003 Jan;125(1):135-43
pubmed: 12538997
Clin Res Cardiol. 2016 Dec;105(12):981-991
pubmed: 27278636
Open Heart. 2015 Jun 26;2(1):e000244
pubmed: 26196019
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
pubmed: 22958960
Heart. 2013 Oct;99(20):1525-9
pubmed: 23697651
J Thorac Cardiovasc Surg. 1968 Nov;56(5):611-6
pubmed: 5697454
Lancet. 2003 Feb 1;361(9355):374-9
pubmed: 12573373
J Magn Reson Imaging. 2009 Feb;29(2):298-304
pubmed: 19161193
Circulation. 2010 Nov 30;122(22):2281-7
pubmed: 21098437
JACC Cardiovasc Imaging. 2013 Feb;6(2):220-34
pubmed: 23489536
Circulation. 2001 Oct 16;104(16):1952-7
pubmed: 11602500
Eur J Cardiothorac Surg. 2008 Nov;34(5):964-8
pubmed: 18774304
Circulation. 2001 Apr 3;103(13):1759-64
pubmed: 11282907
Eur J Echocardiogr. 2010 May;11(4):307-32
pubmed: 20435783
Int J Cardiol. 2011 Jan 7;146(1):73-9
pubmed: 20471120
Mayo Clin Proc. 1970 Apr;45(4):275-85
pubmed: 5439137
J Am Coll Cardiol. 2008 Jan 29;51(4):476-86
pubmed: 18222360
Eur Heart J. 2007 Feb;28(3):326-33
pubmed: 17251259
Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):169-76
pubmed: 26056134
Ann Thorac Surg. 2005 Jul;80(1):170-8
pubmed: 15975362
J Cardiothorac Surg. 2011 Apr 09;6:47
pubmed: 21477334
J Am Coll Cardiol. 2005 Jul 5;46(1):113-9
pubmed: 15992644

Auteurs

Gert Klug (G)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Hans-Josef Feistritzer (HJ)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Sebastian J Reinstadler (SJ)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Martin Reindl (M)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Christina Tiller (C)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Magdalena Holzknecht (M)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Agnes Mayr (A)

Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.

Silvana Müller (S)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Axel Bauer (A)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Bernhard Metzler (B)

University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria. Bernhard.Metzler@tirol-kliniken.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH